- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about LLY
Recent news which mentions LLY
Eli Lilly Alzheimer's Drug Faces Tough Road In UK, Price Watchdog NICE Says Donanemab Is Not Cost-Effective
October 23, 2024
Tickers
LLY
From Benzinga
Decoding Eli Lilly's Options Activity: What's the Big Picture?
October 23, 2024
Tickers
LLY
From Benzinga
3 Simple Vanguard ETFs to Buy With $1,000 and Hold for a Lifetime
October 23, 2024
From Motley Fool
From Motley Fool
Viking Therapeutics Stock Up 240% YTD: Can Q3 Earnings, Weight-Loss Drug Drive Further Gains?
October 22, 2024
From Benzinga
From Benzinga
1 Reason to Buy Eli Lilly Stock Hand Over Fist Right Now
October 19, 2024
Tickers
LLY
From Motley Fool
Investing $10,000 in Each of These 3 Stocks 10 Years Ago Would Have Made You $1.1 Million
October 19, 2024
From Motley Fool
Investigating Eli Lilly's Standing In Pharmaceuticals Industry Compared To Competitors
October 18, 2024
From Benzinga
From Benzinga
2 High-Flying Growth Stocks With Massive Upside Potential
October 17, 2024
From Motley Fool
Tickers
LLY
From Motley Fool
Tickers
LLY
From Motley Fool
Eli Lilly vs. Novo Nordisk: Which Weight Loss Stock is The Better Opportunity Over The Next 10 Years?
October 16, 2024
From Motley Fool
Should Eli Lilly Investors Worry About This Unexpected FDA Move?
October 16, 2024
Tickers
LLY
From Motley Fool
Jim Cramer: 'We Need More Uranium,' Recommends This Stock; Says Novo Nordisk 'Doesn't Hold A Candle' To Big Pharma Rival
October 15, 2024
From Benzinga
From Benzinga
Hims & Hers Health Stock Is Popping Monday: What's Behind The Move?
October 14, 2024
From Benzinga
More Patients On Eli Lilly's Mirikizumab Achieved Histologic Response At One Year Compared To Johnson & Johnson's Drug
October 14, 2024
From Benzinga
'Most Widely Hated' Bull Market Reaches 2-Year Milestone: Top 20 S&P 500 Stocks Driving The Rally
October 14, 2024
From Benzinga
Which Pharma Stock Is the Better Bargain Buy: Pfizer or Eli Lilly?
October 14, 2024
From Motley Fool
From Benzinga
3 No-Brainer Growth Stocks to Buy in October
October 13, 2024
From Motley Fool
Got $500? 2 Magnificent Growth Stocks to Buy and Hold Forever
October 13, 2024
From Motley Fool
Novo Nordisk, Eli Lilly Could Face Downward Pressure Despite Market Dominance From Potentially 16 New Obesity Drugs: See The Names
October 11, 2024
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.